n (%) | |
---|---|
Age median/range (years) | 59 (15-87) |
Sex | |
Male | 42 (52.5%) |
Female | 38 (47.5%) |
BMI (mean ± SD, range) | 22.5 ± 3.1 (16.0-29.1) |
Tumour site | |
Caecum | 10 (12.5%) |
Ascending colon | 46 (57.5%) |
Hepatic flexure | 14 (17.5%) |
Proximal transverse colon | 10 (12.5%) |
pT categorya | |
Tis | 3 (3.75%) |
T1 | 4 (5%) |
T2 | 7 (8.75%) |
T3 | 40 (50%) |
T4 | 26 (32.5%) |
pN categorya | |
pN0 | 37 (46.25%) |
pN1 | 33 (41.25%) |
pN2 | 10 (12.5%) |
pM categorya | |
M0 | 69 (86.25%) |
M1 | 11 (13.75%) |
Stage | |
Stage 0 | 3 (3.75%) |
Stage I | 8 (10%) |
Stage II | 23 (28.75%) |
Stage III | 35 (43.75%) |
Stage IV | 11 (13.75%) |
Surgical approach | |
D2 dissection | 4 (5%) |
CME | 65 (81.25%) |
Multivisceral resection | 7 (8.75%) |
Palliative operation | 4 (5%) |